Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Jul;30(7):1768–1771. doi: 10.1128/jcm.30.7.1768-1771.1992

Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals.

F Chiodi 1, B Keys 1, J Albert 1, L Hagberg 1, J Lundeberg 1, M Uhlén 1, E M Fenyö 1, G Norkrans 1
PMCID: PMC265378  PMID: 1629333

Abstract

Cerebrospinal fluid (CSF) specimens from 63 patients with different severities of human immunodeficiency virus (HIV-1) infection, including asymptomatic virus carriers, were examined for the presence of HIV-1 by using polymerase chain reaction (PCR) and virus isolation. Polyadenylated RNA, presumably associated with virus particles, was extracted and reverse transcribed, and the pol region was amplified in a nested PCR. Virus could be detected in 90% of the CSF specimens examined by PCR, and data on isolation of virus from CSF were in agreement with these figures. In fact, when several CSF specimens from the same individual were studied, HIV-1 could be isolated from 80% of the patients. The presence of the viral RNA in CSF was independent of the clinical stage of infection and of neurological symptoms. These results show that the spread of HIV-1 to the brain represents an early event during infection and occurs in the majority of asymptomatic individuals.

Full text

PDF
1768

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert J., Fenyö E. M. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J Clin Microbiol. 1990 Jul;28(7):1560–1564. doi: 10.1128/jcm.28.7.1560-1564.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asjö B., Morfeldt-Månson L., Albert J., Biberfeld G., Karlsson A., Lidman K., Fenyö E. M. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. 1986 Sep 20;2(8508):660–662. [PubMed] [Google Scholar]
  3. Brinchmann J. E., Albert J., Vartdal F. Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J Virol. 1991 Apr;65(4):2019–2023. doi: 10.1128/jvi.65.4.2019-2023.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1991 Apr;1(3):163–175. doi: 10.1111/j.1750-3639.1991.tb00656.x. [DOI] [PubMed] [Google Scholar]
  5. Budka H., Wiley C. A., Kleihues P., Artigas J., Asbury A. K., Cho E. S., Cornblath D. R., Dal Canto M. C., DeGirolami U., Dickson D. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991 Apr;1(3):143–152. doi: 10.1111/j.1750-3639.1991.tb00653.x. [DOI] [PubMed] [Google Scholar]
  6. Chiodi F., Albert J., Olausson E., Norkrans G., Hagberg L., Sönnerborg A., Asjö B., Fenyö E. M. Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection. AIDS Res Hum Retroviruses. 1988 Oct;4(5):351–358. doi: 10.1089/aid.1988.4.351. [DOI] [PubMed] [Google Scholar]
  7. Chiodi F., Asjö B., Fenyö E. M., Norkrans G., Hagberg L., Albert J. Isolation of human immunodeficiency virus from cerebrospinal fluid of antibody-positive virus carrier without neurological symptoms. Lancet. 1986 Nov 29;2(8518):1276–1277. doi: 10.1016/s0140-6736(86)92699-1. [DOI] [PubMed] [Google Scholar]
  8. Chiodi F., Fenyö E. M. Neurotropism of human immunodeficiency virus. Brain Pathol. 1991 Apr;1(3):185–191. doi: 10.1111/j.1750-3639.1991.tb00658.x. [DOI] [PubMed] [Google Scholar]
  9. Chiodi F., Norkrans G., Hagberg L., Sönnerborg A., Gaines H., Frøland S., Fenyö E. M., Norrby E., Vandvik B. Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation. J Neurol Sci. 1988 Oct;87(1):37–48. doi: 10.1016/0022-510x(88)90052-4. [DOI] [PubMed] [Google Scholar]
  10. Gallo P., Frei K., Rordorf C., Lazdins J., Tavolato B., Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol. 1989 Jul;23(2):109–116. doi: 10.1016/0165-5728(89)90029-5. [DOI] [PubMed] [Google Scholar]
  11. Giulian D., Vaca K., Noonan C. A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 1990 Dec 14;250(4987):1593–1596. doi: 10.1126/science.2148832. [DOI] [PubMed] [Google Scholar]
  12. Goswami K. K., Miller R. F., Harrison M. J., Hamel D. J., Daniels R. S., Tedder R. S. Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. AIDS. 1991 Jul;5(7):797–803. doi: 10.1097/00002030-199107000-00002. [DOI] [PubMed] [Google Scholar]
  13. Goudsmit J., de Wolf F., Paul D. A., Epstein L. G., Lange J. M., Krone W. J., Speelman H., Wolters E. C., Van der Noordaa J., Oleske J. M. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. 1986 Jul 26;2(8500):177–180. doi: 10.1016/s0140-6736(86)92485-2. [DOI] [PubMed] [Google Scholar]
  14. Ho D. D., Rota T. R., Schooley R. T., Kaplan J. C., Allan J. D., Groopman J. E., Resnick L., Felsenstein D., Andrews C. A., Hirsch M. S. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12;313(24):1493–1497. doi: 10.1056/NEJM198512123132401. [DOI] [PubMed] [Google Scholar]
  15. Levy J. A., Shimabukuro J., Hollander H., Mills J., Kaminsky L. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet. 1985 Sep 14;2(8455):586–588. [PubMed] [Google Scholar]
  16. Navia B. A., Jordan B. D., Price R. W. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986 Jun;19(6):517–524. doi: 10.1002/ana.410190602. [DOI] [PubMed] [Google Scholar]
  17. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988 Feb 5;239(4840):586–592. doi: 10.1126/science.3277272. [DOI] [PubMed] [Google Scholar]
  18. Resnick L., Berger J. R., Shapshak P., Tourtellotte W. W. Early penetration of the blood-brain-barrier by HIV. Neurology. 1988 Jan;38(1):9–14. doi: 10.1212/wnl.38.1.9. [DOI] [PubMed] [Google Scholar]
  19. Shaunak S., Albright R. E., Klotman M. E., Henry S. C., Bartlett J. A., Hamilton J. D. Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis. 1990 Jun;161(6):1068–1072. doi: 10.1093/infdis/161.6.1068. [DOI] [PubMed] [Google Scholar]
  20. Shaw G. M., Harper M. E., Hahn B. H., Epstein L. G., Gajdusek D. C., Price R. W., Navia B. A., Petito C. K., O'Hara C. J., Groopman J. E. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11;227(4683):177–182. doi: 10.1126/science.2981429. [DOI] [PubMed] [Google Scholar]
  21. Snider W. D., Simpson D. M., Nielsen S., Gold J. W., Metroka C. E., Posner J. B. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983 Oct;14(4):403–418. doi: 10.1002/ana.410140404. [DOI] [PubMed] [Google Scholar]
  22. Sönnerborg A. B., Ehrnst A. C., Bergdahl S. K., Pehrson P. O., Sköldenberg B. R., Strannegård O. O. HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. AIDS. 1988 Apr;2(2):89–93. doi: 10.1097/00002030-198804000-00003. [DOI] [PubMed] [Google Scholar]
  23. Yarchoan R., Thomas R. V., Grafman J., Wichman A., Dalakas M., McAtee N., Berg G., Fischl M., Perno C. F., Klecker R. W. Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease. Ann Neurol. 1988;23 (Suppl):S82–S87. doi: 10.1002/ana.410230722. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES